Delivery of anti-migraine compounds through an inhalation route

阅读量:

25

申请(专利)号:

US20020152640

申请日期:

2002-05-20

公开/公告号:

US2003021754A1

公开/公告日期:

2003-01-30

申请(专利权)人:

RABINOWITZ JOSHUA D.;ZAFFARONI ALEJANDRO C.

发明人:

JD RabinowitzAC Zaffaroni

展开

被引量:

84

摘要:

The present invention relates to the delivery of anti-migraine compounds through an inhalation route. Specifically, it relates to aerosols containing lidocaine, verapamil, diltiazem, isometheptene, or lisuride that are used in inhalation therapy. In a method aspect of the present invention, lidocaine, verapamil, diltiazem, isometheptene, or lisuride is administered to a patient through an inhalation route. The method comprises: a) heating a thin layer of lidocaine, verapamil, diltiazem, isometheptene, or lisuride, on a solid support to form a vapor; and, b) passing air through the heated vapor to produce aerosol particles having less than 5% drug degradation products. In a kit aspect of the present invention, a kit for delivering lidocaine, verapamil, diltiazem, isometheptene, or lisuride through an inhalation route is provided which comprises: a) a thin coating of a lidocaine, verapamil, diltiazem, isometheptene, or lisuride composition and b) a device for dispensing said thin coating as a condensation aerosol.

展开

通过文献互助平台发起求助,成功后即可免费获取论文全文。

相似文献

参考文献

引证文献

引用走势

2006
被引量:17

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用